CSIR Developes Anti-Diabetes Medicine

▴ CSIR Developes Anti-Diabetes Medicine
For generation of evidences on efficacy & safety of classical Ayurveda formulation on Diabetes Mellitus,CCRAS has done efficacy and safety on formulations viz. Nishamalki churna, Saptvinsti Gugullu, Yasad bhasm, Guduchi churna, Chandraprabha vati, Haridra churna anmd Gokshuradi Gugullu.

The diabetic population in the country is close to hitting the alarming mark of 69.9 million by 2025, which denotes that the country is expected to witness an increase of 266%.

Council of Scientific and Industrial Research (CSIR), through its constituent laboratories namely CSIR-Central Institute of Medicinal & Aromatic Plants (CSIR-CIMAP), Lucknow; and CSIR-National Botanical Research Institute (CSIR-NBRI), Lucknow developed scientifically validated herbal product NBRMAP-DB as anti-diabetic formulation and the knowhow for the product was licensed to M/s AIMIL Pharma Ltd., Delhi who are manufacturing and marketing it as BGR-34, across the country.

M/s AIMIL Pharmaceuticals, the licensee carried out the clinical study of BGR-34 and the trial was registered in clinical trial registry of India (Registration number: CTRI/2016/11/007476). Further, the formulation has shown therapeutic efficacy for treating newly diagnosed type 2 diabetes, as found in independent clinical trials conducted at Banaras Hindu University (BHU), Varanasi.

The Central of Research in Ayurveda Sciences (CCRAS), and autonomous body under Ministry of AYUSH has been engaged in extending research oriented Ayurveda based on integrative health care services for the management of Madhumeha which is Diabetes Mellitus. The following are the core activities

CCRAS in collaboration with Directorate General of Health Services, Ministry of Health & Family Welfare has implemented and executed a programme viz. Integration of AYUSH (Ayurveda) component with NPCDCS(National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular diseases & Stroke ) programme in the identified districts of 3 states viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and Gaya (Bihar) to cater health care services and to reduce the burden of NCDs including Diabetes by combining the strength of Ayurveda and Yoga. The programme was launched during 2016 and continuing in 3 districts viz. Bhilwara (Rajasthan), Surendranagar (Gujarat) and Gaya (Bihar).

The aforesaid programme is now successfully functional in 52 centres (49 CHCs and 3 District Hospitals) of the all 3 identified districts, through AYUSH- NPCDCS Clinic/Lifestyle modification Clinics, established for prevention and management of selected NCDs by Ayurvedic intervention, Lifestyle modifications and Yoga Advice.

CCRAS had developed the AYUSH82 formulation for diabetes through scientific process of drug development and commercialized through National Research Development Corporation (NRDC) for wider public utility.

For generation of evidences on efficacy & safety of classical Ayurveda formulation on Diabetes Mellitus,CCRAS has done efficacy and safety on formulations viz. Nishamalki churna, Saptvinsti Gugullu, Yasad bhasm, Guduchi churna, Chandraprabha vati, Haridra churna anmd Gokshuradi Gugullu.

CCRAS has published the documents viz. Protocol on Prevention and Management for Diabetes Mellitus and compendium on research articles on Diabetes Mellitus which are made available in the public domain for benefit of practitioner’s, physician and researchers

Tags : #CSIR #AntidiabetesMedicine #CCRS

About the Author


Team Medicircle

Related Stories

03 Mar

Dressed for Trust: Why Doctors Must Wear White Aprons Again

With medical institutions gearing up to strictly enforce the rule, professionals are expected to adapt and embrace this change.

View
03 Mar

1.5 Million Bottles Recalled: Is Your ADHD Medication Safe?

As consumers, we must remain vigilant, informed, and proactive in ensuring that the medications we take are truly safe.

View
01 Mar

Are Your Idlis Poisoning You? The Hidden Dangers of Plastic in Indian Kitchens

Awareness campaigns, educational programs, and transparent reporting by food safety authorities can help empower consumers to make better choices.

View
01 Mar

Pregnant and Pained: Is Paracetamol Poisoning Our Unborn Children?

The journey toward safer pregnancy practices is long and challenging, but with collective effort, we can create a future where common medications like paracetamol are used responsibly, ensuring both immediate relief and long-term health benefits.

View
27 Feb

India’s Newborns Are Dying from Sepsis And No One Is Talking About It

Newborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis.

View
27 Feb

A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage Surgery

For those battling severe spinal disorders, this cutting-edge approach offers a new lease on life, free from debilitating pain and limited mobility.

View
27 Feb

Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma Dream

India’s CRDMO sector has the potential to revolutionize the pharmaceutical industry. But will the government step up to unlock its full potential?

View
26 Feb

Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks So

Will the government take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.

View
26 Feb

The Inequality of Survival: Why Some Women Die While Others Live

The projected surge in breast cancer cases and deaths by 2050 is a clear call for immediate and sustained action.

View
26 Feb

The Corporate Invasion of Indian Hospitals: What It Means for You

The question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey.

View

-Advertisements-




Trending Now

1.5 Million Bottles Recalled: Is Your ADHD Medication Safe?March 03, 2025
Dressed for Trust: Why Doctors Must Wear White Aprons AgainMarch 03, 2025
India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?March 01, 2025
Pregnant and Pained: Is Paracetamol Poisoning Our Unborn Children?March 01, 2025
Are Your Idlis Poisoning You? The Hidden Dangers of Plastic in Indian KitchensMarch 01, 2025
Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma DreamFebruary 27, 2025
A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage SurgeryFebruary 27, 2025
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItFebruary 27, 2025
Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks SoFebruary 26, 2025
The Inequality of Survival: Why Some Women Die While Others LiveFebruary 26, 2025
The Corporate Invasion of Indian Hospitals: What It Means for YouFebruary 26, 2025
5 Simple Daily Habits to Keep Your Joints Healthy and Pain-FreeFebruary 25, 2025
Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in IndiaFebruary 25, 2025
With only 70 months left to end AIDS why is the urgency missing?February 25, 2025
Drenched in Oil: Is India Cooking Its Way to an Obesity Epidemic?February 25, 2025
Transforming Education: How Online Learning Platforms are Reshaping Study Material for Board and Competitive ExamsFebruary 24, 2025
February 24, 2025
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaFebruary 24, 2025
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemFebruary 24, 2025
From Science Fiction to Reality: AI Now Detects Blindness Before It StartsFebruary 24, 2025